Global Information
회사소개 | 문의 | 비교리스트

관상동맥혈전증 : 세계 임상시험 리뷰

Coronary Thrombosis Global Clinical Trials Review, H1, 2019

리서치사 GlobalData
발행일 2019년 04월 상품 코드 217237
페이지 정보 영문 43 Pages
가격
US $ 2,500 ₩ 2,971,000 PDF (Single User License) help
1명만 이용할 수 있는 라이선스입니다. PDF 파일은 Copy & Paste가 가능합니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.
US $ 5,000 ₩ 5,942,000 PDF (Site License) help
동일 사업장 내 모든 분들이 공유하여 사용할 수 있습니다. 이용 인원수에 제한은 없습니다. PDF 파일은 Copy & Paste가 가능합니다. PDF 내의 컨텐츠 인쇄는 제한이 없으나, 전체보고서에 대한 제본은 원칙적으로 2부까지만 허용되며, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.
US $ 7,500 ₩ 8,913,000 PDF (Global License) help
동일 기업의 모든 분들이 이용할 수 있는 라이선스입니다. 이용 인원수에 제한은 없으며, 해외 사업장 및 100% 자회사는 동일 기업으로 간주됩니다. PDF 파일은 Copy & Paste가 가능합니다. PDF 내의 컨텐츠 인쇄는 제한이 없으나, 전체보고서에 대한 제본은 원칙적으로 10부까지만 허용되며, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.


관상동맥혈전증 : 세계 임상시험 리뷰 Coronary Thrombosis Global Clinical Trials Review, H1, 2019
발행일 : 2019년 04월 페이지 정보 : 영문 43 Pages

본 상품은 영문 자료로 한글과 영문목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

관상동맥혈전증(Coronary Thrombosis) 치료제 임상시험에 대한 데이터를 조사하고, 국가별 동향, 임상시험 수, 세계의 임상시험소별 모집 상황 등을 전해드립니다.

    1. 목차
    2. 서론
    • 관상동맥혈전증
    • 보고서 개요
    3. 지역별 임상시험
    • 국가별 임상시험
      • 아시아태평양의 주요 국가
      • 유럽의 상위 5개국
      • 북미의 주요 국가
    4. G7 국가의 임상시험
    5. 진척 상황별 : G7 국가의 임상시험
    6. 상(相)별 임상시험
    7. 진척 상황별 임상시험
    8. 미완료 임상시험
    9. 일정기간에 채용된 피험자
    10. 유망한 스폰서
    11. 유망한 약제 비교
    12. 임상시험 프로파일
    • 임상시험 개요 : 상위 기업
      • Abbott Laboratories
    • 임상시험 개요 : 상위 대학, 연구소, 병원
      • Scripps Health
      • Minneapolis Medical Research Foundation
      • Heart Center Bad Krozingen
      • University Hospital Gasthuisberg
      • University of Zurich
      • Samsung Medical Center
      • The University of Hong Kong
      • University Hospital Basel
      • Assistance Publique - Hopitaux de Paris
    13. 5개 주요 임상 프로파일
    부록
    도표
KSM 11.10.19

List of Tables

  • Coronary Thrombosis Therapeutics, Global, Clinical Trials by Region, 2019*
  • Coronary Thrombosis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2019*
  • Coronary Thrombosis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2019*
  • Coronary Thrombosis Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2019*
  • Coronary Thrombosis Therapeutics Clinical Trials, Europe, Top Five Countries, 2019*
  • Coronary Thrombosis Therapeutics Clinical Trials, North America, Top Countries, 2019*
  • Coronary Thrombosis Therapeutics Clinical Trials, Central and South America, Top Countries, 2019*
  • Proportion of Coronary Thrombosis to Cardiovascular Clinical Trials, G7 Countries (%), 2019*
  • Coronary Thrombosis Therapeutics, G7 Countries, Clinical Trials by Phase, 2019*
  • Coronary Thrombosis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2019*
  • Proportion of Coronary Thrombosis to Cardiovascular Clinical Trials, E7 Countries (%), 2019*
  • Coronary Thrombosis Therapeutics, E7 Countries, Clinical Trials by Phase, 2019*
  • Coronary Thrombosis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2019*
  • Coronary Thrombosis Therapeutics, Global, Clinical Trials by Phase, 2019*
  • Coronary Thrombosis Therapeutics, Global, Clinical Trials by Trial Status, 2019*
  • Coronary Thrombosis Therapeutics Clinical Trials, Global, by End Point Status, 2019*
  • Coronary Thrombosis Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2019*
  • Coronary Thrombosis Therapeutics Clinical Trials, Global, Key Sponsors, 2019*
  • Coronary Thrombosis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2019*
  • Coronary Thrombosis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2019*

List of Figures

  • Coronary Thrombosis Therapeutics, Global, Clinical Trials by Region (%), 2019*
  • Coronary Thrombosis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2019*
  • Coronary Thrombosis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2019*
  • Coronary Thrombosis Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2019*
  • Coronary Thrombosis Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2019*
  • Coronary Thrombosis Therapeutics Clinical Trials, North America, Top Countries (%), 2019*
  • Proportion of Coronary Thrombosis to Cardiovascular Clinical Trials, G7 Countries (%), 2019*
  • Coronary Thrombosis Therapeutics, G7 Countries, Clinical Trials by Phase, 2019*
  • Coronary Thrombosis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2019*
  • Proportion of Coronary Thrombosis to Cardiovascular Clinical Trials, E7 Countries (%), 2019*
  • Coronary Thrombosis Therapeutics, E7 Countries, Clinical Trials by Phase, 2019*
  • Coronary Thrombosis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2019*
  • Coronary Thrombosis Therapeutics, Global, Clinical Trials by Phase (%), 2019*
  • Coronary Thrombosis Therapeutics, Global, Clinical Trials by Trial Status, 2019*
  • Coronary Thrombosis Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2019*
  • Coronary Thrombosis Therapeutics Clinical Trials, Global, Key Sponsors, 2019*
  • Coronary Thrombosis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2019*
  • Coronary Thrombosis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2019*
  • GlobalData Methodology

GlobalData's clinical trial report, "Coronary Thrombosis Global Clinical Trials Review, H1, 2019" provides an overview of Coronary Thrombosis clinical trials scenario. This report provides top line data relating to the clinical trials on Coronary Thrombosis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table of Contents

  • List of Tables
  • List of Figures
  • Report Guidance
  • GlobalData Clinical Trials Report Coverage
  • Clinical Trials by Region
  • Clinical Trials and Average Enrollment by Country
  • Clinical Trials by G7 Countries: Proportion of Coronary Thrombosis to Cardiovascular Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Coronary Thrombosis to Cardiovascular Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials in E7 Countries by Trial Status
  • Clinical Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
  • Top Companies Participating in Coronary Thrombosis Therapeutics Clinical Trials
  • Prominent Drugs
  • Clinical Trial Profile Snapshots
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source
Back to Top
전화 문의
F A Q